Metropolis Healthcare Limited (NSE:METROPOLIS)
575.00
+6.30 (1.11%)
Nov 4, 2026, 3:30 PM IST
Metropolis Healthcare Revenue
Metropolis Healthcare had revenue of 5.05B INR in the quarter ending September 30, 2026, with 17.74% growth. This brings the company's total for the last twelve months to 17.83B, up 20.19% year-over-year. In the fiscal year ending March 31, 2026, Metropolis Healthcare had annual revenue of 16.46B with 23.64% growth. That makes Metropolis Healthcare the 17,916th largest company in the world by revenue and 968th in India.
Revenue (ttm)
17.83B
Revenue Growth
+20.19%
P/S Ratio
6.69
Revenue / Employee
3.98M
Employees
4,484
Market Cap
119.29B
Revenue by Geography
- India 15.00B 91.1%
- outside India 1.46B 8.9%
Fiscal year ended Mar 31, 2026 See the full Metropolis Healthcare breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 16.46B | 3.15B | 23.64% |
| Mar 31, 2025 | 13.31B | 1.23B | 10.23% |
| Mar 31, 2024 | 12.08B | 594.99M | 5.18% |
| Mar 31, 2023 | 11.48B | -801.26M | -6.52% |
| Mar 31, 2022 | 12.28B | 2.30B | 23.08% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 616.31B |
| Zydus Lifesciences | 285.92B |
| Divi's Laboratories | 112.30B |
| Laurus Labs | 78.23B |
| Akums Drugs and Pharmaceuticals | 48.29B |
| Marksans Pharma | 31.72B |
| Rainbow Children's Medicare | 19.23B |
| Park Medi World | 17.56B |
Metropolis Healthcare News
- 20 hours ago - Metropolis Healthcare Transcript: Q2 26/27 - Transcripts
- 20 hours ago - Metropolis Healthcare Quarterly report: Q2 2027 - Filings
- 20 hours ago - Metropolis Healthcare Slides: Q2 2027 - Filings
- 2 months ago - Metropolis Healthcare Slides: Investor presentation - Filings
- 3 months ago - Metropolis Healthcare Transcript: Q1 26/27 - Transcripts
- 3 months ago - Metropolis Healthcare Quarterly report: Q1 2027 - Filings
- 3 months ago - Metropolis Healthcare Slides: Q1 2027 - Filings
- 5 months ago - Metropolis Healthcare concall update: Management targets 13-15% growth in FY27 despite Q4 miss - Business Upturn